C

Context Therapeutics
D

CNTX

1.14000
USD
0.01
(0.89%)
مفتوح الان
حجم التداول
5,582
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
104,742,262
الأخبار المقالات

العنوان: Context Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.